Phase Holographic Imaging PHI AB (FRA:L5W) Marketable Securities: €0.00 Mil (As of Oct. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Phase Holographic Imaging PHI AB Marketable Securities?

Phase Holographic Imaging PHI AB FRA:L5W Marketable Securities is €0.00 Mil as of Oct. 2025. The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Phase Holographic Imaging PHI AB's Marketable Securities for the quarter that ended in Oct. 2025 was €0.00 Mil.

Phase Holographic Imaging PHI AB  (FRA:L5W) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Phase Holographic Imaging PHI AB Marketable Securities Related Terms

Phase Holographic Imaging PHI AB Marketable Securities Historical Data

* Premium members only.

The historical data trend for Phase Holographic Imaging PHI AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phase Holographic Imaging PHI AB Marketable Securities Chart

Phase Holographic Imaging PHI AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Phase Holographic Imaging PHI AB Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Phase Holographic Imaging PHI AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Phase Holographic Imaging PHI AB (FRA:L5W) has a Marketable Securities of €0.00 Mil as of Oct. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Phase Holographic Imaging PHI AB and its competitors.
Is Phase Holographic Imaging PHI AB's Marketable Securities too high?
Phase Holographic Imaging PHI AB's current Marketable Securities is €0.00 Mil.
How does Phase Holographic Imaging PHI AB's Marketable Securities compare to ABT and BSX?
Phase Holographic Imaging PHI AB's Marketable Securities of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Phase Holographic Imaging PHI AB and its competitors. Phase Holographic Imaging PHI AB's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phase Holographic Imaging PHI AB stock overvalued right now?
Phase Holographic Imaging PHI AB (FRA:L5W) has a current Marketable Securities of €0.00 Mil. The stock's GF Value™ is €0.23, compared to a current price of €0.04 — trading 81% below its estimated fair value. The current Marketable Securities is €0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Phase Holographic Imaging PHI AB (FRA:L5W), the current Marketable Securities is €0.00 Mil as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Phase Holographic Imaging PHI AB Business Description

Address Skiffervagen 48, Lund, SWE, 224 78
Phase Holographic Imaging PHI AB is a medical device company that develops and markets non-invasive time-lapse imaging instruments used for the quantitative long-term analysis of living cell cultures. The company's commercial HoloMonitor products are based on Quantitative Phase Imaging (QPI) technology, which is used for real-time cell quality evaluation. Geographically, it has presence in Lund, Sweden, with offices in Boston, MA and Winston-Salem, NC.